The Role of New Technologies in Myeloproliferative Neoplasms

The hallmark of BCR-ABL1-negative myeloproliferative neoplasms (MPNs) is the presence of a driver mutation in JAK2, CALR, or MPL gene. These genetic alterations represent a key feature, useful for diagnostic, prognostic and therapeutical approaches. Molecular biology tests are now widely available w...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Giuseppe A., Stella, Stefania, Pennisi, Maria Stella, Pirosa, Cristina, Fermo, Elisa, Fabris, Sonia, Cattaneo, Daniele, Iurlo, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498877/
https://www.ncbi.nlm.nih.gov/pubmed/31106152
http://dx.doi.org/10.3389/fonc.2019.00321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498877/
https://www.ncbi.nlm.nih.gov/pubmed/31106152
http://dx.doi.org/10.3389/fonc.2019.00321

Ejemplares similares